The 100 top-cited studies in cancer immunotherapy.
Objective: The objective of the current study was to identify the 100 top-cited studies in cancer immunotherapy. Materials and methods: A retrospective bibliometric analysis was performed in March 2019. Studies were searched on the Web of Science to identify the 100 top-cited studies in cancer immunotherapy. Studies were identified and analysed for authorship, journal, study type, year of publication and institution. Results: The 100 top-cited papers were cited from 591 to 5332 times and were published between 1986 and 2016. They were published in 27 journals, and New England Journal of Medicine published most of the studies (n = 14), followed by Nature (n = 11) and Journal of Clinical Oncology (n = 10). They were published from 10 countries, and the USA published most of the studies (n = 82), followed by France (n = 5) and Netherlands (n = 3). National Cancer Institute in USA was the leading institution and Rosenberg, SA was the most productive author. Conclusions: This study provides insights into development and most important papers in cancer immunotherapy and will provide evidence for future research in cancer immunotherapy.